3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
27
Observational
6
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
13
Gynecologic
4
Genitourinary
4
Thoracic
3
Gastrointestinal
3
Lymphoid
2
Breast
2
Plasma cell
1
Other solid neoplasm
1
Myeloid
1
Dermatologic
1
CNS
1
Conditions
Multiple Myeloma
32
Recurrence
10
Lymphoma, Non-Hodgkin
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Granuloma, Plasma Cell
2
Waldenstrom Macroglobulinemia
1
Sarcoma
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Interventions
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Sarcoma
×
Plasma cell
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available